Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.645 USD | +5.91% | +5.31% | +16.73% |
May. 13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
May. 13 | Earnings Flash (CAPR) CAPRICOR THERAPEUTICS Posts Q1 Revenue $4.9M, vs. Street Est of $9.7M | MT |
Financials (USD)
Sales 2024 * | 22.1M | Sales 2025 * | 89.52M | Capitalization | 168M |
---|---|---|---|---|---|
Net income 2024 * | -38M | Net income 2025 * | 4M | EV / Sales 2024 * | 7.6 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.88 x |
P/E ratio 2024 * |
-4.54
x | P/E ratio 2025 * |
1,066
x | Employees | 102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.77% |
Latest transcript on Capricor Therapeutics, Inc.
1 day | +5.91% | ||
1 week | +5.31% | ||
Current month | +8.31% | ||
1 month | -3.75% | ||
3 months | +58.11% | ||
6 months | +85.32% | ||
Current year | +16.73% |
Managers | Title | Age | Since |
---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 60 | 13-11-19 |
Anthony Bergmann
DFI | Director of Finance/CFO | 38 | 13-11-19 |
Kristi Elliott
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Philip Gotwals
BRD | Director/Board Member | 61 | 23-07-20 |
Earl Collier
BRD | Director/Board Member | 76 | 13-11-19 |
George Dunbar
BRD | Director/Board Member | 77 | 13-11-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 5.73 | +7.50% | 352 747 |
24-05-15 | 5.33 | +2.50% | 284,300 |
24-05-14 | 5.2 | -4.41% | 667,284 |
24-05-13 | 5.44 | +2.64% | 193,872 |
24-05-10 | 5.3 | -2.21% | 233,835 |
Delayed Quote Nasdaq, May 16, 2024 at 02:56 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.73% | 168M | |
+7.71% | 113B | |
+10.40% | 106B | |
+0.41% | 22.27B | |
-11.91% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.36% | 17.24B | |
+7.02% | 14.29B | |
+36.25% | 12.52B |
- Stock Market
- Equities
- CAPR Stock